(Press-News.org) February 1, 2021 - Researchers have identified another good reason to eat more mushrooms. New research , published in Food Science & Nutrition (January 2021) found that adding a mushroom serving to the diet increased the intake of several micronutrients, including shortfall nutrients such as vitamin D, without any increase in calories, sodium or fat.
Dr. Victor L. Fulgoni III and Dr. Sanjiv Agarwal modeled the addition of mushrooms to National Health and Nutrition Examination Survey (NHANES) 2011-2016 dietary data looking at a composite of white, crimini and portabella mushrooms at a 1:1:1 ratio; one scenario including UV-light exposed mushrooms; and one scenario including oyster mushrooms for both 9-18 years and 19+ years of age based on an 84g or ½ cup equivalent serving.
Key findings include:
Adding an 84g serving of mushrooms increased several shortfall nutrients including potassium and fiber. This was true for the white, crimini and portabella 1:1:1 mix and the oyster mushrooms.
The addition of a serving (84 g) of mushrooms to the diet resulted in an increase in dietary fiber (5%-6%), copper (24%-32%), phosphorus (6%), potassium (12%-14%), selenium (13%-14%), zinc (5%-6%), riboflavin (13%-15%), niacin (13%-14%), and choline (5%-6%) in both adolescents and adults; but had no impact on calories, carbohydrate, fat or sodium.
When commonly consumed mushrooms are exposed to UV-light to provide 5 mcg vitamin D per serving, vitamin D intake could meet and slightly exceed the recommended daily value (98% - 104%) for both the 9 -18 year and 19+ year groups as well as decrease inadequacy of this shortfall nutrient in the population.
A serving of UV-light exposed commonly consumed mushrooms decreased population inadequacy for vitamin D from 95.3% to 52.8% for age group 9-18 years and from 94.9% to 63.6% for age group 19+ years.
"This research validated what we already knew that adding mushrooms to your plate is an effective way to reach the dietary goals identified by the DGA ," said Mary Jo Feeney, MS, RD, FADA and nutrition research coordinator to the Mushroom Council. "Data from surveys such as NHANES are used to assess nutritional status and its association with health promotion and disease prevention and assist with formulation of national standards and public health policy (CDC, 2020)."
Mushrooms are fungi - a member of the third food kingdom - biologically distinct from plant and animal-derived foods that comprise the USDA food patterns yet have a unique nutrient profile that provides nutrients common to both plant and animal foods. Although classified into food grouping systems by their use as a vegetable, mushrooms' increasing use in main entrees in plant-forward diets is growing, supporting consumers' efforts to follow food-based dietary guidance recommendations to lower intake of calories, saturated fatty acids, and sodium while increasing intake of under-consumed nutrients including fiber, potassium and vitamin D. Often grouped with vegetables, mushrooms provide many of the nutrient attributes of produce, as well as attributes more commonly found in meat, beans or grains.
According to the USDA's FoodData Central , 5 medium raw, white mushrooms (90g) contain 20 calories, 0g fat, 3g protein and are very low in sodium (0mg/ END
Just add mushrooms: Making meals more nutritious
Understanding the nutritional impact of adding a serving of mushrooms on usual intakes and population nutrient adequacy using NHANES 2011-2016 data
2021-02-01
ELSE PRESS RELEASES FROM THIS DATE:
Larger panel finds more gene mutations, treatment targets for leukemia
2021-02-01
AUGUSTA, Ga. (Feb. 1, 2020) - A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
The 523-gene panel, developed by San Diego-based biotech company Illumina, which includes all genes known to potentially cause cancer, can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML, the investigators report in the journal PLOS ONE.
Identifying ...
Patient-reported outcomes from the randomized phase III CROWN study of first-line Lorlatinib versus in ALK+ NSCLC
2021-01-31
(Singapore--January 31, 2021 2:40 p.m. SPT 1:40 a.m. EST)--Patient-reported outcomes from the phase III CROWN study showed that time to treatment deterioration (TTD) in pain in chest, dyspnea, and cough was comparable between those who received lorlatinib and patients who took crizotinib. The research was presented today at the International Association for the Study of Lung Cancer's 2020 World Conference on Lung Cancer Singapore.
Lorlatinib, a third-generation ALK inhibitor, significantly improved progression-free survival compared to crizotinib in ...
Social & structural factors influence racial disparities in COVID-19 mortality
2021-01-31
COVID-19 mortality racial disparities in the U.S. are associated with social factors like income, education and internet access, according to a Rutgers study.
The study, published in the Journal of Racial and Ethnic Health Disparities, highlights the need for public health policies that address structural racism.
The researchers investigated the association between COVID-19 cases and deaths in 2,026 U.S. counties from January to October 2020 and social determinants of health, which can raise the risk for infection and death.
They also looked at factors known or thought to impact COVID-19 outcomes, including the counties' population density, days since the first COVID-19 death and percent of residents who are over age 65, are smokers or who have chronic diseases such as obesity, ...
ERAS program expedites recovery for congenital heart surgery patients
2021-01-30
CHICAGO (January 30, 2021) -- Select patients born with heart defects and who undergo congenital heart surgery recover with few complications and reduced opioid use when a comprehensive, evidence-based enhanced recovery after surgery (ERAS) program is used, according to research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.
"We have embarked on a new paradigm for patient care with the goal of improving recovery, patient experience, and the value of care that we provide," said Nathalie Roy, MD, from Boston Children's Hospital in Massachusetts. ...
Women undergo less aggressive open heart surgery, experience worse outcomes than men
2021-01-30
CHICAGO (January 30, 2021) -- Women are significantly less likely than men to undergo coronary artery bypass grafting (CABG) using guideline-recommended approaches, which may result in worse outcomes after surgery, according to a scientific presentation at the 57th Annual Meeting of The Society of Thoracic Surgeons.
"This study highlights key differences between women and men in surgical techniques used for CABG and reveals opportunities to improve outcomes in women," said Oliver K. Jawitz, MD, from Duke University in Durham, North Carolina.
Using the STS Adult Cardiac Surgery Database--which contains records of nearly all CABG procedures performed in the US--Dr. Jawitz and colleagues from Duke and The Johns Hopkins University ...
'COVID effect' leads to fewer heart surgeries, more patient deaths
2021-01-30
CHICAGO (January 30, 2021) -- The most deadly global health crisis in a century has resulted in a substantial decline in overall heart surgery volume and an unexplained increase in deaths after coronary artery bypass grafting, according to late-breaking research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.
"This study was a true herculean analysis and tour de force that showed the COVID effect on adult cardiac surgery volume, trends, and outcomes," said Tom C. Nguyen, MD, from the University of California San Francisco. "The pandemic has changed the world as we know it, causing a dramatic drop in adult cardiac surgery volume and worsening patient outcomes."
Dr. Nguyen and colleagues queried the STS Adult ...
Nivolumab effective treatment for malignant mesothelioma
2021-01-30
(Singapore--January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)-- Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Malignant mesothelioma is an intractable cancer, and no phase III trial has yet shown an improvement in overall survival following the standard first line chemotherapy doublet comprising pemetrexed and cisplatin or carboplatin since it was licensed in 2004.
Professor Dean Fennell, chair of Thoracic Medical Oncology at the University of Leicester in collaboration with Professor Gareth Griffiths and his team at the Southampton Clinical Trials Unit, University of Southampton, ...
Selected gene mRNA expression is not predictive of improved overall survival
2021-01-30
(Singapore--January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)-- A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Lung cancer researchers and clinicians have sought methods to improve chemotherapy's modest 5% overall survival rate for patients with NSCLC. Dr. Silvia Novello, professor of medical oncology at the University of Torino at ...
LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate
2021-01-30
(Singapore--January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)-- Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated by patients and met its primary endpoint of 20% major pathologic response rate, according to research presented today at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer.
Dr. Jay M. Lee, chief, Division of Thoracic Surgery at Ronald Reagan UCLA Medical Center in Los Angeles, today reported on results from a study of 181 patients with stage IB to IIIB non-small cell lung ...
TALENT study supports NLCST and NELSON trial results
2021-01-30
(Singapore--January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)-- A study presented today by researchers with the Ministry of Health and Welfare in Taiwan confirmed the effectiveness of low-dose computed tomography (LDCT) screening in a pre-defined, never-smoker, high-risk population. The research was presented today at the International Association for the Study of Lung Cancer 2021 World Conference on Lung Cancer.
In Taiwan, lung cancer is the leading cause of cancer mortality, and 53% of those have died of lung cancer were never-smokers. The National Lung Cancer Screening Trial (NLCST) and NELSON Trials demonstrated that the use of low-dose CT is effective for lung cancer screening; however, ...
LAST 30 PRESS RELEASES:
Glowing bacterial sensors detect gut illness in mice before symptoms emerge
GLP-1 RAs and prior major adverse limb events in patients with diabetes
Life-course psychosocial stress and risk of dementia and stroke in middle-aged and older adults
Cells have a built-in capacity limit for copying DNA, and it could impact cancer treatment
Study finds longer hospital stays and higher readmissions for young adults with complex childhood conditions
Study maps how varied genetic forms of autism lead to common features
New chip-sized, energy-efficient optical amplifier can intensify light 100 times
New light-based platform sets the stage for future quantum supercomputers
Pesticides significantly affect soil life and biodiversity
Corals sleep like us, but their symbiosis does not rest
Huayuan biota decodes Earth’s first Phanerozoic mass extinction
Beyond Polymers: New state-of-the-art 3D micro and nanofabrication technique overcomes material limitations
New platform could develop vaccines faster than ever before
TF-rs1049296 C>T variant modifies the association between hepatic iron stores and liver fibrosis in metabolic dysfunction-associated steatotic liver disease
ASH publishes clinical practice guidelines on diagnosis of light chain amyloidosis
SLAS receives grant from Alfred P. Sloan Foundation to develop lab automation educational guidelines
Serum interleukin-8 for differentiating invasive pulmonary aspergillosis from bacterial pneumonia in patients with HBV-associated acute-on-chronic liver failure
CIIS and the Kinsey Institute present "Desire on the Couch," an exhibition examining psychology and sexuality
MRI scan breakthrough could spare thousands of heart patients from risky invasive tests
Kraft Center at Mass General Brigham launches 2nd Annual Kraft Prize for Excellence and Innovation in Community Health
New tool shows how to enter and change pneumocystis fungi
Applications of artificial intelligence and smart devices in metabolic dysfunction-associated steatotic liver disease
New clinical trial demonstrates that eating beef each day does not affect risk factors for type 2 diabetes
Powering AI from space, at scale
New Watson College seed grants encourage interdisciplinary research
A new immune evasion pathway in cancer reveals statins as immunotherapy boosters
Understanding how smart polymer solutions transition to gels around body temperature
Thermal transport modulation in YbN-alloyed ALN thin films to the glassy limit
Being a night owl may increase your heart risk
Parental firearm injury linked to increased mental health burden in children
[Press-News.org] Just add mushrooms: Making meals more nutritiousUnderstanding the nutritional impact of adding a serving of mushrooms on usual intakes and population nutrient adequacy using NHANES 2011-2016 data

